Innovation and growth in the life sciences sector often require complex commercial agreements, ranging from R&D collaborations, to licensing agreements and M&A transactions. Given the complexity and long-term perspective of many of these arrangements, companies need to understand what options are available when disagreements with their partners arise.
Join a group of Baker McKenzie's European disputes, life sciences and IP experts to discuss how disputes in the life sciences sector can be avoided, managed and resolved.
|17h00||Welcome and introduction|
|17h10||Setting the scene: contractual arrangements around the creation and transfer of value in the life sciences sector|
|17h40||A practitioner’s view on dispute resolution mechanisms (litigation, arbitration, mediation) in the context of commercial transactions in the life sciences sector|
|18h10||How early case assessment and procedural risk analysis can help to avoid and manage disputes|
|18h40||Panel-led discussion: Managing collaborations and conflicts in practice|
Dispute Avoidance and Management in the Life Sciences Sector
Date & Time
LocationZunfthaus zur Saffran